VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ICUI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ICUIICU Medical, Inc.
$172.11$4.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksICUIBalance Sheet

ICU Medical, Inc. (ICUI) Balance Sheet

30Y historyFree accessUpdated daily

Debt-to-equity improved to 0.59 from 0.82 over the past year as total debt fell to $1.3B, though goodwill of $1.5B represents 37.5% of total assets and warrants monitoring for impairment.

Income StatementBalance SheetCash FlowRatios

ICUI Balance Sheet

Annual statement

ICUI Balance Sheet

ICU Medical, Inc. (ICUI) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets1.22B1.18B1.44B1.22B1.24B1.03B914.38M882.2M927.04M864.66M569.1M505.01M437.21M394.3M325.5M262.99M207.83M207.94M179.39M153.26M171.44M137.76M117.04M111.22M114.21M90.4M67.2M49.4M47.9M41.1M38.2M
Cash & Short-Term Investments301.78M307.96M308.57M254.72M213.01M567.25M410.78M292.64M382.11M300.13M445.08M377.4M346.76M296.89M226.16M159.99M93.36M108.14M111.79M95.64M116.92M86.74M87.34M73.14M88.47M73.03M50.79M38.4M2M3M2.1M
Cash Only301.78M307.96M308.57M254.22M208.78M552.83M396.1M268.67M344.78M290.07M445.08M336.16M275.81M226.02M146.9M99.59M78.85M51.25M55.7M7.87M13.15M6.85M5.62M1.79M4.17M3.9M1.95M1.9M2M3M2.1M
Short-Term Investments000501K4.22M14.42M14.69M23.97M37.33M10.06M041.23M70.95M70.87M79.26M60.4M14.51M56.89M56.09M87.77M103.77M79.89M81.72M71.35M84.3M69.13M48.84M36.5M000
Accounts Receivable206.26M180.51M202.7M182.15M246.9M124.81M127.77M202.22M196.44M149.12M59.11M57.85M39.05M45.32M49.13M43.57M55.11M47.78M38.42M26.11M26.61M24.82M11.56M29.09M16.63M13.06M12.43M7.1M6.5M3.4M3M
Days Sales Outstanding33.7129.5531.0629.4339.5334.6136.6958.2951.2142.1156.8761.846.0952.7356.5952.6370.6875.3268.550.6648.1757.5155.8398.8969.1469.0480.7155.1459.6140.8244.51
Inventory607.27M615.86M584.68M709.36M696.01M290.24M314.93M337.64M311.16M288.66M49.26M43.63M36.93M34.45M36.33M40.42M44.06M41.33M17.93M19.5M16.32M15.44M8.43M3.4M5.75M1.59M1.44M2.1M2M1.8M2.2M
Days Inventory Outstanding166.17159.38137.04170.42160.56128.44142155.15136.83121.59101.039985.479.0982.792.31104.43122.9456.9564.7849.2463.9377.225.657.5520.1127.3247.9151.0561.495.6
Other Current Assets104.56M47.63M321.42M41.01M43.05M20.27M25.24M27.16M21.1M38.89M13.99M18.5M10.5M10.32M11.56M10.84M14.63M8.71M6.7M9.26M7.06M7M3.14M2.01M1.71M2.11M2.55M1.8M37.4M32.9M30.9M
Total Non-Current Assets2.72B2.86B2.76B3.16B3.28B850.93M849.32M810.18M658.36M632.29M135.59M121.82M103.89M105.35M103.01M100.7M104.39M101.22M104.05M89.34M72.81M66.78M47.72M53.07M42.82M26.94M25.66M26M14.5M10.1M11.4M
Property, Plant & Equipment481.16M506.29M499.3M685.52M713.58M510.88M513.2M490.55M432.64M398.68M85.7M74.32M86.09M87.86M85.94M83.05M83.55M78.39M69.9M72.71M59.04M52.19M40.93M41.04M34.61M25.12M23.92M24.4M13.8M9.6M10.9M
Fixed Asset Turnover4.42x4.40x4.77x3.30x3.20x2.58x2.48x2.58x3.24x3.24x4.43x4.60x3.59x3.57x3.69x3.64x3.41x2.95x2.93x2.59x3.42x3.02x1.85x2.62x2.54x2.75x2.35x1.93x2.88x3.17x2.26x
Goodwill1.48B1.5B1.43B1.47B1.45B43.44M33M31.25M11.2M12.36M5.58M6.46M1.48M1.48M1.48M1.48M1.48M1.48M0000000000000
Intangible Assets536.47M633.56M740.79M870.59M982.77M188.31M197.23M211.41M133.42M143.75M22.38M23.94M7.06M8.49M9.95M11.42M14.81M16.78M10.78M11.88M9.78M10.96M2.78M4.17M0000000
Long-Term Investments526.1M131.59M8.76M3.12M3.69M7.86M12.97M02.02M14.58M-21.93M-17.1M-13.94M-7.52M97.37M00-3.71M11.35M000-1.16M00000000
Other Non-Current Assets69.16M62.88M56.11M88.19M99.69M57.83M61.88M48.98M40.42M38.14M21.93M17.1M13.94M7.52M-97.37M004.57M8.16M2.31M1.11M2.9M4.01M5.18M3.9M856K1.74M1.6M700K500K500K
Total Assets3.94B4.05B4.2B4.38B4.52B1.88B1.76B1.69B1.59B1.5B704.69M626.83M541.1M499.64M428.51M363.69M312.23M309.15M283.43M242.59M244.25M204.54M164.77M164.29M157.03M117.34M92.86M75.4M62.4M51.2M49.6M
Asset Turnover0.55x0.55x0.57x0.52x0.50x0.70x0.72x0.75x0.88x0.86x0.54x0.55x0.57x0.63x0.74x0.83x0.91x0.75x0.72x0.78x0.83x0.77x0.46x0.65x0.56x0.59x0.61x0.62x0.64x0.59x0.50x
Asset Growth %-14.92%-3.65%-3.99%-3.04%140.1%6.64%4.21%6.75%5.91%112.43%12.42%15.84%8.3%16.6%17.82%16.48%0.99%9.07%16.83%-0.68%19.42%24.14%0.29%4.62%33.82%26.36%23.16%20.83%21.88%3.23%3.55%
Total Current Liabilities514.63M498.86M556.18M481.84M494.56M200.78M195.49M248.47M249.29M210.29M40.54M42.62M28.73M26.89M29.12M29.31M25.76M33.7M21.96M21.48M15.92M13.89M7.45M8.29M11.64M10.66M9.48M7.4M4.1M3.2M2.7M
Accounts Payable142.99M154.37M148.02M150.03M215.9M81.13M71.86M128.63M120.47M78.23M14.64M13.67M11.38M11.34M11.31M13.25M10.88M18.42M7.88M8.44M8.13M5.08M2.69M3.05M5.05M2.4M1.69M1M700K1.4M1.9M
Days Payables Outstanding42.3339.9534.6936.0449.8135.932.459.152.9832.9530.0331.0226.3126.0225.7430.2625.7954.8125.0328.0324.5421.0324.6622.9950.5130.2932.1122.8117.8747.7682.56
Short-Term Debt18.75M34.67M51M51M29.69M09.29M000000000000000000000000
Deferred Revenue (Current)212.24M33.84M30.36M31.64M30.84M12.65M5.57M6.7M3.81M3.33M000000254K2.39M0000000000000
Other Current Liabilities10.09M134.25M103.17M71.21M42.93M33.11M53.51M15.22M58.61M67.31M12.28M8.14M1.37M05.16M3.68M5.61M5.34M07.67M2.38M4.22M2.31M0007.79M6.4M3.4M1.8M800K
Current Ratio2.37x2.36x2.59x2.53x2.50x5.13x4.68x3.55x3.72x4.11x14.04x11.85x15.22x14.67x11.18x8.97x8.07x6.17x8.17x7.14x10.77x9.92x15.70x13.42x9.81x8.48x7.09x6.68x11.68x12.84x14.15x
Quick Ratio1.19x1.13x1.54x1.06x1.09x3.68x3.07x2.19x2.47x2.74x12.82x10.83x13.93x13.38x9.93x7.59x6.36x4.94x7.35x6.23x9.74x8.81x14.57x13.01x9.31x8.33x6.94x6.39x11.20x12.28x13.33x
Cash Conversion Cycle157.56148.98133.4163.81150.28127.14146.29154.33135.07130.75127.88129.78105.18105.8113.55114.67149.32143.46100.4387.4272.87100.41108.36101.576.1858.8675.9180.2392.7954.4757.55
Total Non-Current Liabilities1.24B1.43B1.68B1.77B1.93B63.93M65.94M66.67M72.45M88.41M4M4.34M4.12M8.03M8.54M11.22M12.18M10.45M8.44M7.21M3.08M529K000000100K100K200K
Long-Term Debt1.13B1.31B1.53B1.58B1.62B00000000000000000000000000
Capital Lease Obligations133.28M47.68M43.11M54.93M62.77M36.04M43.41M28.9M00000000000000000000000
Deferred Tax Liabilities73.26M37.76M48.81M55.87M126.01M1.49M1.66M2.09M721K1.49M1.37M1.37M1.38M3.63M5.25M7.14M8.02M5.7M8.44M4.33M3.08M529K0000000100K200K
Other Non-Current Liabilities95.89M32.52M49.69M74.04M102.46M26.4M19.67M35.12M71.73M86.92M2.63M2.96M2.75M4.4M3.29M4.08M4.16M4.75M02.89M00000000100K00
Total Liabilities1.75B1.93B2.24B2.26B2.43B264.71M261.43M315.14M321.74M298.7M44.53M46.95M32.85M34.92M37.66M40.53M37.94M44.15M30.4M28.69M19M14.42M7.45M8.29M11.64M10.66M9.48M7.4M4.2M3.3M2.9M
Total Debt1.15B1.39B1.64B1.7B1.73B45.05M52.7M36.26M00000000000000000000000
Net Debt850.07M1.08B1.33B1.45B1.53B-507.78M-343.4M-232.41M-344.78M-290.07M-445.08M-336.16M-275.81M-226.02M-146.9M-99.59M-78.85M-51.25M-55.7M-7.87M-13.15M-6.85M-5.62M-1.79M-4.17M-3.9M-1.95M-1.9M-2M-3M-2.1M
Debt / Equity0.53x0.66x0.84x0.80x0.83x0.03x0.04x0.03x-----------------------
Debt / EBITDA3.28x4.52x6.25x6.77x9.02x0.21x0.27x0.20x-----------------------
Net Debt / EBITDA2.42x3.52x5.08x5.76x7.93x-2.38x-1.78x-1.26x-3.58x-5.63x-4.36x-3.88x-4.72x-3.16x-1.83x-1.19x-1.18x-0.96x-1.22x-0.22x-0.31x-0.18x-0.39x-0.04x-0.12x-0.14x-0.09x-0.11x-0.16x-0.30x-0.26x
Interest Coverage1.00x1.03x0.38x0.24x-0.62x144.72x56.62x209.94x278.08x26.05x722.73x1788.15x-------------------
Total Equity2.19B2.12B1.97B2.12B2.09B1.62B1.5B1.38B1.26B1.2B660.15M579.87M508.25M464.73M390.86M323.16M274.29M265M253.03M213.9M225.25M190.12M157.31M156M145.39M106.68M83.38M68M58.2M47.9M46.7M
Equity Growth %19.04%8.07%-7.45%1.6%29.32%7.57%9.08%8.99%5.46%81.51%13.85%14.09%9.37%18.9%20.95%17.82%3.5%4.73%18.29%-5.04%18.47%20.85%0.84%7.3%36.29%27.94%22.62%16.84%21.5%2.57%2.19%
Book Value per Share87.1585.2880.5888.1487.5674.1969.5863.9258.5057.4538.2635.1532.4830.4326.5422.8219.8017.6917.3714.0114.4412.6410.5210.379.477.386.145.224.613.983.52
Total Shareholders' Equity2.19B2.12B1.97B2.12B2.09B1.62B1.5B1.38B1.26B1.2B660.15M579.87M508.25M464.73M390.86M323.16M274.29M265M253.03M213.9M224.89M189.2M156.35M156M145.39M106.68M83.38M68M58.2M47.9M46.7M
Common Stock2.52M2.47M2.45M2.41M2.4M2.13M2.11M2.07M2.05M2.02M1.63M1.61M1.56M1.51M1.49M1.49M1.49M1.48M1.48M1.48M1.48M1.42M1.42M1.42M1.41M887K887K900K000
Retained Earnings766.96M690.89M690.16M807.85M837.5M911.79M808.65M721.78M620.75M585.62M516.98M453.9M408.91M382.58M342.16M303.46M258.79M227.86M201.3M177M153.93M128.26M107.99M102.99M80.69M61.01M45.61M33.4M24.2M16.9M11.3M
Treasury Stock-23.04M-22K-92K-262K-243K-27K-39K-157K-95K0-14K00-49K-15.13M-35.35M-41.43M-19.88M-1.62M-40.78M-5.38M-609K-15.29M-12.12M0-987K-4.82M-7.2M000
Accumulated OCI-42.17M-34.63M-139.4M-53.08M-80.98M-19.27M-1.52M-15.4M-16.95M-14.96M-21.27M-20.76M-9.55M2.19M-1.43M-3.23M-1.06M1.19M902K1.4M381K-28K480K177K-24.35M-19.82M-16.21M-12.5M-9.1M-7.1M-5.2M
Minority Interest00000000000000000000358K923K966K00000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStable
Balance SheetMixed
Cash FlowStable
Top Statement Risk

Revenue contraction persists

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Leverage Easing as Assets Shrink

Total assets contracted from $4.3B to $4.0B over the past year while debt fell from $1.7B to $1.3B, per recent balance sheet data, suggesting deleveraging despite revenue decline.

The balance sheet is gradually strengthening as total liabilities dropped from $2.2B to $1.8B over the last five quarters, while equity rose from $2.0B to $2.2B. This deleveraging appears driven by debt repayment and retained earnings accumulation, even as revenue contracts. The asset reduction may reflect divestitures or write-downs, but the improving equity cushion suggests a stabilizing financial base.

Debt Reduction Improves Leverage Profile

Debt-to-equity improved from 0.82 in early 2024 to 0.59 by Q2 2026, as total debt fell from $1.7B to $1.3B, according to reported figures, indicating a deliberate deleveraging trend.

The absolute debt reduction of roughly $400M over ten quarters appears strategic, likely aimed at reducing interest burden post-Smiths Medical acquisition. The D/E ratio now sits below peers like BDX (0.76) and ITGR (0.80), suggesting improved financial flexibility. However, the absolute debt level remains substantial relative to equity, and refinancing risk may persist if rates stay elevated, though the trend is favorable.

Asset Base Shrinks with Goodwill Dominance

Goodwill remains flat at $1.5B, representing 37.5% of total assets, while net PPE declined from $670M to $485M over ten quarters, per balance sheet data, indicating a shift toward intangible-heavy assets.

The high goodwill concentration, largely from the Smiths Medical acquisition, exposes the balance sheet to potential impairment if revenue contraction persists. The decline in net PPE suggests either reduced capital expenditure or asset disposals, which may signal a more asset-light model but could also reflect underinvestment in manufacturing capacity. Investors should monitor whether the shrinking asset base aligns with revenue stabilization.

Equity Builds on Retained Earnings

Retained earnings rose from $768M in Q1 2024 to $740M in Q2 2026, despite a dip to $675M in Q1 2025, as per financial statements, indicating a gradual accumulation of profits.

The equity base expanded from $2.0B to $2.2B over the period, driven by retained earnings and reduced debt, even as net income remained volatile. The absence of dividends and modest buybacks suggests management is prioritizing balance sheet repair over shareholder returns. The positive retained earnings trajectory, despite revenue decline, implies that margin improvements are translating into equity growth.

Liquidity Buffer Remains Solid

Current ratio improved to 2.43 in Q2 2026 from 2.29 in Q3 2024, with cash stable around $300M, according to balance sheet data, indicating a robust short-term liquidity position.

The current ratio consistently above 2.0 suggests ample coverage of short-term obligations, with cash levels sufficient to cover roughly 10% of total liabilities. This liquidity buffer provides a cushion against operational shocks, such as supply chain disruptions or integration delays. However, the stable cash balance despite debt repayment may indicate that operating cash flow is being used to service debt rather than build reserves.

Goodwill Impairment Risk Looms

Goodwill of $1.5B, unchanged over ten quarters, represents a significant 37.5% of total assets, per balance sheet data, and may be at risk if revenue decline continues.

The persistent revenue contraction of 6.4% YoY raises the risk that the carrying value of goodwill from the Smiths Medical acquisition may not be fully recoverable. If the company's market capitalization or cash flow projections deteriorate, an impairment charge could erode equity and distort the apparent balance sheet strength. Investors should monitor whether the recent margin improvements are sufficient to offset top-line weakness and support the goodwill valuation.

ICUI — Frequently Asked Questions

Quick answers to the most common questions about buying ICUI stock.

What are the total assets of ICU Medical, Inc. (ICUI)?

As of 2025, ICU Medical, Inc. (ICUI) had total assets of $4.05B including $1.18B in current assets.

How much debt does ICU Medical, Inc. (ICUI) have?

ICU Medical, Inc. (ICUI) carries total debt of $1.39B, offset by $308.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of ICU Medical, Inc.?

ICU Medical, Inc. (ICUI) has total shareholders' equity (book value) of $2.12B ($85.28 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is ICU Medical, Inc.'s current ratio and liquidity?

ICU Medical, Inc. (ICUI) reported a current ratio of 2.36x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.